Clinical Trials Browser

OTHER × Lymphoma × ixazomib × Clear all

NCT02898259 2022-09-26

Lenalidomide, Ixazomib, and Rituximab as Front-Line Therapy for High Risk Indolent B-Cell Lymphoma

Phase 1/2 Terminated

19 enrolled 15 charts

Lymphoma, Lymphoma, B-Cell

NCT02169791 2021-09-02

Nonmyeloablative Haploidentical Transplant Followed by MLN9708

Phase 2 Completed

29 enrolled 14 charts

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Hematologic Neoplasms

NCT03422874 2018-02-06

Dose Escalation Study of Nelfinavir Plus MLN9708 in Patients With Advanced Solid Tumors or Lymphoma

Phase 1 Withdrawn

Lymphoma, Neoplasms